Top-News
04.12.25
JDE Peet’s prices EUR 600 million senior unsecured notes issue
PRESS RELEASE
04.12.25
Participation notification by UBS Group AG
Press release                                                                  Regulated information
04.12.25
Press Release: Sanofi completes acquisition of Vicebio
Sanofi completes acquisition of Vicebio
04.12.25
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
Ad Hoc Announcement Pursuant to Art. 53 LR
04.12.25
Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
03.12.25
Signify completes cancellation of 5.8 million shares
Press Release
02.12.25
dsm-firmenich completes €1.08 billion share repurchase program
Press Release
02.12.25
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of November 30, 2025 (Article 223-16 of the General Regulations of the ...
02.12.25
Eurocastle announces Director/PDMR Dealing Notification
EUROCASTLE INVESTMENT LIMITED
02.12.25
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to ...
02.12.25
Progress on share buyback programme
Progress on share buyback programme
01.12.25
GLOBAL BIOENERGIES: judicial liquidation and delisting of shares
Evry, 01 December 2025 – 5:30pm: At the hearing to examine the bids held on November 24, the Evry Commercial Court examined the two final takeover bids submitted. In a ruling ...
01.12.25
Kitron to host Capital Markets Presentation
Kitron to host Capital Markets Presentation
01.12.25
Aalberts N.V.: Aalberts reports progress on divestment programme
Utrecht, 1 December 2025
01.12.25
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
PARIS, FRANCE, 1 DECEMBER 2025 - It is with great sadness that Ipsen (Euronext: IPN; ADR: IPSEY) today announces that Henri Beaufour, Ipsen Board Member and a ...
01.12.25
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
Geneva, Switzerland, December 1, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-​stage biopharmaceutical company focused on developing a portfolio of novel ...
01.12.25
Nokia Corporation’s Financial Calendar for 2026
Nokia Corporation Stock Exchange Release 1 December 2025 at 8:00 EET Nokia Corporation’s Financial Calendar for 2026
28.11.25
Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
Daix (France), New York City (New York, United States), November 28, 2025  – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-​stage biopharmaceutical company ...
27.11.25
Success of Capgemini’s 12th Employee Share Ownership Plan
Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 E-mail: victoire.grux@capgemini.com
27.11.25
Rapala VMC Corporation to Redeem its Outstanding Hybrid Capital Securities Issued in 2023
Rapala VMC Corporation, Stock Exchange Release, November 27, 2025 at 06:00 p.m. EET